Phase I trial of the safety and immunogenicity of three doses of an intranasal norwalk virus-like particle vaccine
Latest Information Update: 06 Dec 2011
At a glance
- Drugs Norovirus vaccine recombinant monovalent Takeda (Primary)
- Indications Norovirus infections
- Focus Adverse reactions; Pharmacodynamics
Most Recent Events
- 16 Feb 2011 New trial record